Metastatic Prostate Cancer x Dr. Charles Ryan 2025 UPDATE

Dr. Charles Ryan, a leading GU oncologist from MSK in NYC, returns to share vital updates on metastatic prostate cancer. He discusses the differences between castrate-sensitive and castrate-resistant prostate cancer, crucial for treatment strategies. Advancements like PARP inhibitors and immunotherapy take center stage, alongside the necessity for genomic testing. Ryan emphasizes learning from clinical trials, whether outcomes are positive or negative. He also inspires future oncologists by showcasing the stunning progress in cancer treatment, blending research with heartfelt encouragement.